510(k) for Minntech's hemoconcentrator:
This article was originally published in Clinica
The FDA has cleared Minntech's Hemocor HPH 700 hemoconcentrator for use during open-heart surgery. The device removes excess fluid in the blood stream while retaining, or concentrating, the patient's red blood cells to minimise the need for donor blood. Due to its "no-rinse" technology, the product can be inserted into the bypass circuit at any time during the surgical procedure, the Minneapolis-based company said.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.